194 related articles for article (PubMed ID: 31016899)
1. Expanding the phenotype for the recurrent p.Ala391Glu variant in FGFR3: Beyond crouzon syndrome and acanthosis nigricans.
Rymer K; Shiang R; Hsiung A; Pandya A; Bigdeli T; Webb BT; Rhodes J
Mol Genet Genomic Med; 2019 Jun; 7(6):e656. PubMed ID: 31016899
[TBL] [Abstract][Full Text] [Related]
2. [Acanthosis nigricans in children and Crouzon syndrome].
Lagaude M; Barreau M; Jokic M; Gerard M; DiRocco F; Hadj-Rabia S; Dompmartin A; Verneuil L
Ann Dermatol Venereol; 2014 Nov; 141(11):685-8. PubMed ID: 25442473
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.
Meyers GA; Orlow SJ; Munro IR; Przylepa KA; Jabs EW
Nat Genet; 1995 Dec; 11(4):462-4. PubMed ID: 7493034
[TBL] [Abstract][Full Text] [Related]
4. Subtle radiographic findings of achondroplasia in patients with Crouzon syndrome with acanthosis nigricans due to an Ala391Glu substitution in FGFR3.
Schweitzer DN; Graham JM; Lachman RS; Jabs EW; Okajima K; Przylepa KA; Shanske A; Chen K; Neidich JA; Wilcox WR
Am J Med Genet; 2001 Jan; 98(1):75-91. PubMed ID: 11426459
[TBL] [Abstract][Full Text] [Related]
5. A recurrent mutation, ala391glu, in the transmembrane region of FGFR3 causes Crouzon syndrome and acanthosis nigricans.
Wilkes D; Rutland P; Pulleyn LJ; Reardon W; Moss C; Ellis JP; Winter RM; Malcolm S
J Med Genet; 1996 Sep; 33(9):744-8. PubMed ID: 8880573
[TBL] [Abstract][Full Text] [Related]
6. Crouzon with acanthosis nigricans. Further delineation of the syndrome.
Arnaud-López L; Fragoso R; Mantilla-Capacho J; Barros-Núñez P
Clin Genet; 2007 Nov; 72(5):405-10. PubMed ID: 17935505
[TBL] [Abstract][Full Text] [Related]
7. A newborn with acanthosis nigricans: can it be Crouzon syndrome with acanthosis nigricans?
Sharda S; Panigrahi I; Gupta K; Singhi S; Kumar R
Pediatr Dermatol; 2010; 27(1):43-7. PubMed ID: 20199409
[TBL] [Abstract][Full Text] [Related]
8. Mild achondroplasia/hypochondroplasia with acanthosis nigricans, normal development, and a p.Ser348Cys FGFR3 mutation.
Couser NL; Pande CK; Turcott CM; Spector EB; Aylsworth AS; Powell CM
Am J Med Genet A; 2017 Apr; 173(4):1097-1101. PubMed ID: 28181399
[TBL] [Abstract][Full Text] [Related]
9. Crouzon syndrome with acanthosis nigricans: case report and mutational analysis.
Nagase T; Nagase M; Hirose S; Ohmori K
Cleft Palate Craniofac J; 2000 Jan; 37(1):78-82. PubMed ID: 10670894
[TBL] [Abstract][Full Text] [Related]
10. FGFR3 overactivation in the brain is responsible for memory impairments in Crouzon syndrome mouse model.
Cornille M; Moriceau S; Khonsari RH; Heuzé Y; Loisay L; Boitez V; Morice A; Arnaud E; Collet C; Bensidhoum M; Kaci N; Boddaert N; Paternoster G; Rauschendorfer T; Werner S; Mansour SL; Di Rocco F; Oury F; Legeai-Mallet L
J Exp Med; 2022 Apr; 219(4):. PubMed ID: 35254402
[TBL] [Abstract][Full Text] [Related]
11. Prominent basal emissary foramina in syndromic craniosynostosis: correlation with phenotypic and molecular diagnoses.
Robson CD; Mulliken JB; Robertson RL; Proctor MR; Steinberger D; Barnes PD; McFarren A; Müller U; Zurakowski D
AJNR Am J Neuroradiol; 2000 Oct; 21(9):1707-17. PubMed ID: 11039354
[TBL] [Abstract][Full Text] [Related]
12. Clinical signs, interventions, and treatment course of three different treatment protocols in patients with Crouzon syndrome with acanthosis nigricans.
de Planque CA; Wall SA; Dalton L; Paternoster G; Arnaud É; van Veelen MC; Versnel SL; Johnson D; Jayamohan J; Mathijssen IMJ
J Neurosurg Pediatr; 2021 Aug; 28(4):425-431. PubMed ID: 34388723
[TBL] [Abstract][Full Text] [Related]
13. Crouzon syndrome with acanthosis nigricans: a case-based update.
Di Rocco F; Collet C; Legeai-Mallet L; Arnaud E; Le Merrer M; Hadj-Rabia S; Renier D
Childs Nerv Syst; 2011 Mar; 27(3):349-54. PubMed ID: 21136065
[TBL] [Abstract][Full Text] [Related]
14. Molecular diagnosis of bilateral coronal synostosis.
Mulliken JB; Steinberger D; Kunze S; Müller U
Plast Reconstr Surg; 1999 Nov; 104(6):1603-15. PubMed ID: 10541159
[TBL] [Abstract][Full Text] [Related]
15. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans.
Vajo Z; Francomano CA; Wilkin DJ
Endocr Rev; 2000 Feb; 21(1):23-39. PubMed ID: 10696568
[TBL] [Abstract][Full Text] [Related]
16. Mild isolated craniosynostosis due to a novel FGFR3 mutation, p.Ala334Thr.
Barroso E; Pérez-Carrizosa V; García-Recuero I; Glucksman MJ; Wilkie AO; García-Minaur S; Heath KE
Am J Med Genet A; 2011 Dec; 155A(12):3050-3. PubMed ID: 22038757
[TBL] [Abstract][Full Text] [Related]
17. Crouzon with Acanthosis Nigricans and Odontogenic Tumors: A Rare Form of Syndromic Craniosynostosis.
Xu W; McDonald-McGinn DM; Melchiorre AJ; Zackai EH; Bartlett SP; Taylor JA
Cleft Palate Craniofac J; 2018 Feb; 55(2):296-300. PubMed ID: 29351036
[TBL] [Abstract][Full Text] [Related]
18. Hearing loss in syndromic craniosynostoses: otologic manifestations and clinical findings.
Agochukwu NB; Solomon BD; Muenke M
Int J Pediatr Otorhinolaryngol; 2014 Dec; 78(12):2037-47. PubMed ID: 25441602
[TBL] [Abstract][Full Text] [Related]
19. Crouzon syndrome with acanthosis nigricans and prominent diffuse hyperpigmentation associated with gain-of-function A391E mutation in FGFR3 gene.
Kariya H; Nakano H; Ishii N; Kaimi Y; Imai K; Nakanishi Y; Kunihiro N; Fukai K
J Dermatol; 2020 Dec; 47(12):e451-e452. PubMed ID: 32860240
[No Abstract] [Full Text] [Related]
20. Multiple consequences of a single amino acid pathogenic RTK mutation: the A391E mutation in FGFR3.
Chen F; Sarabipour S; Hristova K
PLoS One; 2013; 8(2):e56521. PubMed ID: 23437153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]